Neuropeptides
Volume 44, Issue 1 , Pages 53-56 , February 2010

Effect of serotonergic system on AVP secretion induced by physical exercise

Received 13 July 2009 ,Accepted 15 October 2009.

References 

  1. Akavich PF, Rieg TS, Ahamed I, Lautero JJ. Fluoxetin induces vasopressin and oxytocin abnormalities in food restricted rats given voluntary exercise: relationship to anorexia nervosa. Brain Res. 1993;612:180–189
  2. Bagdy G, Sved AF, Murphy DL, Szemered K. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma subtypes: renin activity responses to serotonin agonists. Eur. J. Pharmacol. 1992;210:285–289
  3. Chiodera P, Volpi R, Capretti L, Caffarri G, Magotti MG, Coiro V. Different effects of the serotonergic agonist buspirone and sumatriptan on the posterior pituitary hormonal responses to hypoglycaemia in humans. Neuropeptides. 1996;30:187–192
  4. Gibbs DM, Vale W. Effect of serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophyseal-portal blood. Brain Res. 1983;280:176–179
  5. Holmes MC, Renzo GD, Becford LI, Gillman B, Jones MT. Role of serotonin in the control of secretion of corticotropin releasing factor. J. Endocrinol. 1982;93:151–160
  6. Iovino M, Steardo L. Effect of substances influencing brain serotonergic transmission on plasma vasopressin levels in the rat. Eur. J. Phrmacol. 1985;113:99–103
  7. Meensen R, Watson P, Hasegawa H, Roelands B, Piacentini MF. Central fatigue. The serotonin hypothesis and beyond. Sport Med. 2006;36:881–909
  8. Pergola PE, Sved AF, Voogt JL, Alper RH. Effect of serotonin on vasopressin release: a comparison to corticosterone, prolactin and renin. Neuroendocrinology. 1993;57:550–558
  9. Rivier C, Vale W. Neuroendocrine interaction between corticotropin releasing factor and vasopressin on adrenocorticotropin hormone secretion in the rat. In:  Schrier RW editors. Vasopressin. New York: Raven Press; 1985;p. 181–188
  10. Thompson CJ, Jones IR, Walker M, Baylis PH, Kendall Taylor P. The effects of the specific serotonin antagonist ICI 169–369 on the pituitary hormone response to insulin-induced hypoglycemia in humans. Clin. Endocrinol. 1992;36:235–240
  11. Van der Kar LD. Neuroendocrine pharmacology of serotonergic (%-HT) neurons. Ann. Rev. Pharmacol. Toxicol. 1991;31:187–320
  12. Volpi R, Chiodera P, Giuliani N, Capretti L, Caffarri G, Magotti MG, et al. 5-HT3 serotonergic receptor mediation of hypoglycaemia-induced arginine–vasopressin but not oxytocin secretion in normal men. J. Endocrinol. Invest. 1998;21:7–11

PII: S0143-4179(09)00113-9

doi: 10.1016/j.npep.2009.10.004

Neuropeptides
Volume 44, Issue 1 , Pages 53-56 , February 2010

Article Tools

* Image Usage & Resolution